Old Web
English
Sign In
Acemap
>
authorDetail
>
M. van Kruchten
M. van Kruchten
Medicine
Pathology
Positron emission tomography
Nuclear medicine
Radiology
4
Papers
16
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Grand Round : Reversible impaired methotrexate clearance after platinum-based chemotherapy for osteosarcoma
2019
Therapeutic Drug Monitoring
T H Oude Munnink
A. Van der Meer
J.J. de Haan
Daniel J. Touw
M. van Kruchten
Show All
Source
Cite
Save
Citations (0)
The value of PET/CT with FES or FDG tracers in metastatic breast cancer: a computer simulation study in ER-positive patients
2015
British Journal of Cancer
Rositsa G. Koleva-Kolarova
Marcel J. W. Greuter
M. van Kruchten
Karin M. Vermeulen
Talitha Feenstra
Erik Buskens
A.W.J.M. Glaudemans
E. F. J. de Vries
E.G.E. de Vries
Geke A.P. Hospers
G. H. de Bock
Show All
Source
Cite
Save
Citations (16)
16{alpha}-[18f]fluoro-17ss-estradiol (FES)-PET to detect ER-positive tumor lesions in patients with breast cancer with a diagnostic dilemma.
2010
Journal of Clinical Oncology
M. van Kruchten
A.W.J.M. Glaudemans
E. F. J. de Vries
C. P. Schroder
E.G.E. de Vries
Geesiena Hospers
Show All
Source
Cite
Save
Citations (0)
16 alpha-[F-18]-fluoro-17 beta-estradiol positron emission tomography (FES-PET) to detect ER positive tumor lesions in breast cancer patients with a diagnostic dilemma
2010
European Journal of Nuclear Medicine and Molecular Imaging
A.W.J.M. Glaudemans
M. van Kruchten
R. H. J. A. Slart
Rudi Dierckx
Geesiena Hospers
Emma De Vries
Erik F. J. de Vries
Show All
Source
Cite
Save
Citations (0)
1